Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Just In
Election case: Trump's âprivate criminal conductâ detailed in new document unsealed in case against former president
Just In
Donate now: WRAL's Hurricane Recovery Telethon is happening now. Call 919-595-5005 to donate
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Tonix Pharm Holdings
(NQ:
TNXP
)
0.1305
-0.0050 (-3.69%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tonix Pharm Holdings
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 28, 2023
We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
July 27, 2023
Via
Benzinga
Tonix Acquires Two FDA-Approved, Marketed Migraine Products From Upsher-Smith Laboratories
July 03, 2023
Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP)
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
May 25, 2023
On Thursday, 221 companies hit new 52-week lows.
Via
Benzinga
A New Depression Drug Being Developed by Tonix May Side-Step Treatment-Limiting Effects of Nearly All Current Antidepressants in the US
April 27, 2023
Via
ACCESSWIRE
Stocks That Hit 52-Week Lows On Wednesday
May 24, 2023
On Wednesday, 129 stocks made new 52-week lows.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 09, 2023
Via
Benzinga
A New Depression Drug Being Developed By Tonix May Side-Step Treatment-Limiting Effects Of Nearly All Current Antidepressants In The US
April 27, 2023
The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The sponsored content team works to ensure...
Via
Benzinga
Tonix Pharmaceuticals Fast Forwards Its Fibromyalgia, Migraine Studies
April 13, 2023
Via
Benzinga
Tonix Pharma Deprioritizes COVID-19 Related Programs, Pending PTSD Trial
April 04, 2023
Via
Benzinga
Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today?
December 12, 2022
TNXP stock traders are in a bidding war today as Tonix announces a possible game-changer in Covid-19 treatment methodologies.
Via
InvestorPlace
Sidoti & Company, LLC Announces Registration Now Open for March Small-Cap and May Micro-Cap Conferences
February 14, 2023
Via
ACCESSWIRE
Tonix Pharmaceuticals Seeks To Bolster Its COVID-19 Pipeline With This New Acquisition
February 02, 2023
Via
Benzinga
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
January 24, 2023
Tonix mAb Technology Aims to Extend the Utility and Durability of COVID Medicines for Immunocompromised and Other Risk Populations
Via
Benzinga
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
January 24, 2023
by Faith Ashmore - Benzinga
Via
TheNewswire.com
Exposures
COVID-19
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
January 24, 2023
Tonix CEO Calls for New Class of Covid-19 Pre-Exposure and Therapeutic Antibodies for High-Risk Populations
Via
News Direct
Exposures
COVID-19
Recap: Tonix Pharmaceuticals Q3 Earnings
November 07, 2022
Tonix Pharmaceuticals (NASDAQ:TNXP) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 19, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 11, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 06, 2023
Via
Benzinga
Crude Oil Rises Sharply; Adicet Bio Shares Plunge
December 12, 2022
U.S. stocks traded higher midway through trading, with the Dow Jones gaining over 250 points on Monday
Via
Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
January 06, 2023
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process.
Via
Benzinga
Why Is Reborn Coffee (REBN) Stock Up 34% Today?
December 12, 2022
Reborn Coffee (REBN) stock is heating up on Monday as investors take note of the California coffee company's shares with heavy trading.
Via
InvestorPlace
Why Is Harpoon Therapeutics (HARP) Stock Up 100%+ Today?
December 12, 2022
Harpoon Therapeutics (HARP) stock is taking off on Monday following the release of updated results from its myeloma drug candidate.
Via
InvestorPlace
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
December 12, 2022
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share.
Via
Benzinga
Why Tonix Pharmaceuticals Stock Is Rocketing Higher Today
December 12, 2022
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading higher Monday after the company announced the exclusive license of potential therapeutic or preventative humanized anti-SARS-CoV-2
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 12, 2022
Via
Benzinga
Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session
November 16, 2022
Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process.
Via
Benzinga
Threats For New Outbreak Looms, As Scientists Signal Deadly Monkeypox Variant Circulating In Central Africa
November 03, 2022
Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks. After analyzing 1,463 cases...
Via
Benzinga
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.